Lack of oversight by CMS to ensure private Medicare drug plans have anti-fraud programs in place ‘risks significant use of funds,’ according to GAO
August 28th, 2008 | by admin |
Pharmaceutical News
CMS has not conducted audits to ensure that Medicare prescription drug plans have implemented programs to prevent fraud as required by law, a lack of oversight that “risks significant misuse of funds in this $39 billion program,” according to a Government Accountability Office report scheduled for release width=396 align=left vspace=5 border=0>This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Stumble it!
